Simulation Study on Multi-Regional Clinical Trial

碩士 === 國立臺北大學 === 統計學系 === 100 === In the current drug development strategy, MRCT (Multiregional Clinical Trial) are increased to support the researchers as much as possible the use of the concept of global clinical trials to drug development and human trials. However, among various regions of the w...

Full description

Bibliographic Details
Main Authors: Hsu, Chia-Min, 許家敏
Other Authors: Ou, Shyh-Tyan
Format: Others
Language:zh-TW
Published: 2012
Online Access:http://ndltd.ncl.edu.tw/handle/63636610571594847100
id ndltd-TW-100NTPU0337018
record_format oai_dc
spelling ndltd-TW-100NTPU03370182015-10-13T21:12:10Z http://ndltd.ncl.edu.tw/handle/63636610571594847100 Simulation Study on Multi-Regional Clinical Trial 多區域臨床試驗之模擬探討 Hsu, Chia-Min 許家敏 碩士 國立臺北大學 統計學系 100 In the current drug development strategy, MRCT (Multiregional Clinical Trial) are increased to support the researchers as much as possible the use of the concept of global clinical trials to drug development and human trials. However, among various regions of the world, difference of races, genes, food culture, drug usages and clinical practices will have an impact on the efficacy and safety of drugs and dosage range. It is apparent to see drug lags occurred in the Asia region. How to shorten the length of drug lag becomes an important issue in Asia. It is a proper way to make use of the race similarity between Taiwanes and Japanese, we conduct BSE (Bridging Study Evaluation) to the approved new drug in Japan which the global clinical trials include Japanese. For those into the Japanese species of global clinical trials for the test sample, its approval of new drugs marketed in Japan, of BSE. This can effectively reduce the delay of the phenomena of drugs, the introduction of new drugs and a considerable degree of security. For this purpose, we have two methods currently used to assess whether new drugs are listed, the text known as Method 1 and Method 2, do the different conditions in-depth comparison and understanding, and the objective results of the simulation data, as paper the results of verification. Most importantly, of results, and look forward to as a reference for Taiwan's pharmaceutical regulatory agencies. Ou, Shyh-Tyan Jeff Lin 歐士田 林建甫 2012 學位論文 ; thesis 67 zh-TW
collection NDLTD
language zh-TW
format Others
sources NDLTD
description 碩士 === 國立臺北大學 === 統計學系 === 100 === In the current drug development strategy, MRCT (Multiregional Clinical Trial) are increased to support the researchers as much as possible the use of the concept of global clinical trials to drug development and human trials. However, among various regions of the world, difference of races, genes, food culture, drug usages and clinical practices will have an impact on the efficacy and safety of drugs and dosage range. It is apparent to see drug lags occurred in the Asia region. How to shorten the length of drug lag becomes an important issue in Asia. It is a proper way to make use of the race similarity between Taiwanes and Japanese, we conduct BSE (Bridging Study Evaluation) to the approved new drug in Japan which the global clinical trials include Japanese. For those into the Japanese species of global clinical trials for the test sample, its approval of new drugs marketed in Japan, of BSE. This can effectively reduce the delay of the phenomena of drugs, the introduction of new drugs and a considerable degree of security. For this purpose, we have two methods currently used to assess whether new drugs are listed, the text known as Method 1 and Method 2, do the different conditions in-depth comparison and understanding, and the objective results of the simulation data, as paper the results of verification. Most importantly, of results, and look forward to as a reference for Taiwan's pharmaceutical regulatory agencies.
author2 Ou, Shyh-Tyan
author_facet Ou, Shyh-Tyan
Hsu, Chia-Min
許家敏
author Hsu, Chia-Min
許家敏
spellingShingle Hsu, Chia-Min
許家敏
Simulation Study on Multi-Regional Clinical Trial
author_sort Hsu, Chia-Min
title Simulation Study on Multi-Regional Clinical Trial
title_short Simulation Study on Multi-Regional Clinical Trial
title_full Simulation Study on Multi-Regional Clinical Trial
title_fullStr Simulation Study on Multi-Regional Clinical Trial
title_full_unstemmed Simulation Study on Multi-Regional Clinical Trial
title_sort simulation study on multi-regional clinical trial
publishDate 2012
url http://ndltd.ncl.edu.tw/handle/63636610571594847100
work_keys_str_mv AT hsuchiamin simulationstudyonmultiregionalclinicaltrial
AT xǔjiāmǐn simulationstudyonmultiregionalclinicaltrial
AT hsuchiamin duōqūyùlínchuángshìyànzhīmónǐtàntǎo
AT xǔjiāmǐn duōqūyùlínchuángshìyànzhīmónǐtàntǎo
_version_ 1718057793777303552